Lose Weight With GLP-1s, Get Judged More Than if You’d Done Nothing
GLP-1 medications quieted the food noise. They didn’t quiet the judgment.
Posted May 19, 2026 | Reviewed by Michelle Quirk
Think about how much mental space food has taken up in your life.
Not hunger. The non-stop buzzing that starts before breakfast and doesn’t stop until you fall asleep—and sometimes follows you into your dreams . You’re at a work meeting, and you’re thinking about what you’ll have for lunch. You’re with your kids, and you’re calculating whether you can have the bread at dinner. You’re lying in bed at night, composing tomorrow’s plan for doing it right this time. The constant low-grade negotiation between desire and control that runs underneath everything else you’re trying to do. For many women, this is just called daily life.
Researchers have a name for it now: food noise. A 2025 survey of 550 people on semaglutide found that before treatment, 62 percent reported constant food-related thoughts throughout the day. After starting treatment, that number dropped to 16 percent (INFORM survey, EASD 2025). For many women, this is experienced not as a side effect but as a revelation: the sudden awareness of how much cognitive and emotional labor had been consumed, for years, by something they assumed was just part of being them.
The Paradox Nobody Warned Us About
Here is what the research is finding: The quiet inside didn’t stop the noise outside.
A 2026 study published in the International Journal of Obesity —conducted by psychologists at Rice University, the Mayo Clinic, and UCLA—found that women who lost weight using GLP-1 medications were judged more harshly than women who hadn’t lost weight at all. Not just rated below women who lost weight through diet and exercise. Rated below women who changed nothing.
“The GLP-1 users were socially penalized not just compared to someone who lost weight through diet and exercise,” said lead author Erin Standen. “They were also rated more harshly than someone who didn’t lose weight in the first place.”
The finding cuts at something deeper than stigma . What is being evaluated is not only how you look. It is how you look—and the visible effort it took to get there.
Why the Judgment Finds a New Address
To understand why, it helps to look at what the judgment was always about.
Weight, in Western culture, is not purely a health matter. Research by Quinn and Crocker, published in the Journal of Personality and Social Psychology , showed that women who subscribed to Protestant ethic beliefs—that discipline and self- denial signal moral worth—experienced significantly worse psychological well-being when they felt overweight. Thinness has long functioned as visible proof of character: that you resisted, deprived yourself, stayed in control.
GLP-1 medications expose that story as fiction. Appetite is a neurobiological process involving reward circuitry, hormonal signaling, and dopamine pathways. Researchers have found that semaglutide reduces cravings not only for food but also for alcohol and cigarettes, suggesting the medications dampen reward-driven behavior at a biological level (Hendershot et al., JAMA Psychiatry , 2025). The struggle was real. The idea that we have full control over our own appetites was not.
But when biology explains what we once called weakness, moral judgment doesn’t dissolve. It moves somewhere else.
GLP-1 use is consistently described—across cultures—as “cheating” and “taking the easy way out.” The scrutiny doesn’t vanish; it migrates to new questions.
Is this even real weight loss? Will it last without the medication ? Is this something you actually earned, or something you bought? Can you afford to stay on it? If you stop and regain weight, was that failure? If you stay on it indefinitely, is that dependence? And are you being transparent about it—or letting people assume your results came from discipline?
That last question is telling. In my clinical work and in my current qualitative research with women on GLP-1 medications, I hear a version of it often: women who continue going to the gym, who mention what they’ve been eating, who make their effort visible—not because it’s medically necessary, but because they feel the need to show that the medication isn’t doing all the work. The food noise stopped. The performance of deserving the results did not.
The woman who spent years demonstrating she could resist temptation is now working to demonstrate she earned what the medication gave her. The arena changed. The expectation—that her body is something she must prove mastery over—did not.
What This Asks of Us, Psychologically
There is a distinction I keep returning to, both in the therapy room and in my own thinking: the difference between sustainable care and moral performance.
Sustainable care asks: What does this body actually need? What allows me to function, feel well, and be present in my life?
Moral performance asks: What will prove I am doing this correctly? What makes my choices legible as virtuous—to the people watching, or to the voice inside that sounds a lot like them?
That second voice is the one worth examining—because it doesn’t only come from outside. Women absorb the cultural logic of self-denial so thoroughly that it often becomes indistinguishable from their own values. The judgment that feels like conscience . The guilt that registers as information.
No medication changes the culture that produced it. But naming what the culture is asking—and recognizing when we’ve internalized the ask—is where the psychological work actually begins.
If food noise was always a neurological experience, not a character flaw, then the quiet it created was never something to be earned.
It was just relief. And relief, it turns out, is allowed.
Standen, E. C., Phelan, S. M., & Tomiyama, A. J. (2026). An experimental investigation of the stigmatization of weight loss and regain from GLP-1 receptor agonist use and cessation. International Journal of Obesity. https://doi.org/10.1038/s41366-026-02061-y
Hendershot, C. S., et al. (2025). Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry, 82(4), 395–405. https://doi.org/10.1001/jamapsychiatry.2024.4789
Quinn, D. M., & Crocker, J. (1999). When ideology hurts: Effects of belief in the Protestant ethic and feeling overweight on the psychological well-being of women. Journal of Personality and Social Psychology , 77(2), 402–414.
INFORM Survey. (2025). Semaglutide and food noise outcomes in adults with overweight or obesity. Presented at the European Association for the Study of Diabetes (EASD) Annual Meeting, Vienna.
Heitmann, B. L., et al. (2025). Beyond the prescription: Global observations on the social implications of GLP-1 receptor agonists for weight loss. PLOS Global Public Health. https://doi.org/10.1371/journal.pgph.0005516
Ringel, M. M., & Ditto, P. H. (2019). The moralization of obesity. Social Science & Medicine, 237, 112399.
Share this post Facebook Bluesky Linkedin Email
Yael Hallak is a NY Licensed Mental Health Counselor, researcher at The New School’s Gender & Health Lab, and journalist at Haaretz writing about women, health, and the psychology of self-control.
Get the help you need from a therapist near you–a FREE service from Psychology Today.
This article is part of the Bringwise Psychology Journal — daily insights on human behavior, mental health, and personal growth.